Search research articles
Contact Us
Filters
Showing results (101-110 of 125) with videos related to
Page
of 13
Sort By:
Pathologie-Biologie
|
January 1, 1990
[Neuropeptides and inflammation: presumed mechanisms in neurogenic inflammation]
Y Landry, J G Bloch, M Mousli, et al.
Planta Medica
|
February 1, 1985
Inhibition of mast cell histamine release by flavonoids and biflavonoids
M Amellal, C Bronner, F Briancon, et al.
European Journal of Pharmacology
|
November 14, 1994
Gastrin releasing peptide-preferring bombesin binding sites in human lung
E Lach, D H Coy, P Dumont, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 30, 1998
The M2 muscarinic receptor antagonist methoctramine activates mast cells via pertussis toxin-sensitive G proteins
A Chahdi, L Daeffler, J L Bueb, et al.
Agents and Actions
|
April 1, 1990
Role of phospholipase A2 and G-proteins in the IgE-dependent activation of mast cells and macrophages
C Bronner, V Cothenet, D Monté, et al.
Journal of Healthcare Management / American College of Healthcare Executives
|
January 5, 2019
CEO Turnover Among U.S. Acute Care Hospitals, 2006-2015: Variations by Type of Geographic Area
Larry R Hearld, William Opoku-Agyeman, Dae Hyun Kim, et al.
European Journal of Pharmacology
|
March 15, 1995
Structural requirements for neuropeptide Y in mast cell and G protein activation
M Mousli, A Trifilieff, J T Pelton, et al.
Agents and Actions
|
April 1, 1985
Potential anti-anaphylactic activity of clenbuterol, a beta-agonist with calcium antagonist properties
N Frossard, J C Frankhuyzen-Sierevogel, M Binck, et al.
Planta Medica
|
February 1, 1985
Inhibition of mast cell histamine release by flavonoids and biflavonoids
M Amella, C Bronner, F Briancon, et al.
Agents and Actions
|
April 1, 1990
The sensitivity to Zn2+ discriminates between typical and atypical mast cells
M Mousli, J P Gies, C Bertrand, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 125) with videos related to
Sort By:
Page
of 13
Pathologie-Biologie
|
January 1, 1990
[Neuropeptides and inflammation: presumed mechanisms in neurogenic inflammation]
Y Landry, J G Bloch, M Mousli, et al.
Planta Medica
|
February 1, 1985
Inhibition of mast cell histamine release by flavonoids and biflavonoids
M Amellal, C Bronner, F Briancon, et al.
European Journal of Pharmacology
|
November 14, 1994
Gastrin releasing peptide-preferring bombesin binding sites in human lung
E Lach, D H Coy, P Dumont, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 30, 1998
The M2 muscarinic receptor antagonist methoctramine activates mast cells via pertussis toxin-sensitive G proteins
A Chahdi, L Daeffler, J L Bueb, et al.
Agents and Actions
|
April 1, 1990
Role of phospholipase A2 and G-proteins in the IgE-dependent activation of mast cells and macrophages
C Bronner, V Cothenet, D Monté, et al.
Journal of Healthcare Management / American College of Healthcare Executives
|
January 5, 2019
CEO Turnover Among U.S. Acute Care Hospitals, 2006-2015: Variations by Type of Geographic Area
Larry R Hearld, William Opoku-Agyeman, Dae Hyun Kim, et al.
European Journal of Pharmacology
|
March 15, 1995
Structural requirements for neuropeptide Y in mast cell and G protein activation
M Mousli, A Trifilieff, J T Pelton, et al.
Agents and Actions
|
April 1, 1985
Potential anti-anaphylactic activity of clenbuterol, a beta-agonist with calcium antagonist properties
N Frossard, J C Frankhuyzen-Sierevogel, M Binck, et al.
Planta Medica
|
February 1, 1985
Inhibition of mast cell histamine release by flavonoids and biflavonoids
M Amella, C Bronner, F Briancon, et al.
Agents and Actions
|
April 1, 1990
The sensitivity to Zn2+ discriminates between typical and atypical mast cells
M Mousli, J P Gies, C Bertrand, et al.
Page
of 13